Melperon Forte Neuraxpharm (Melperone Hydrochloride)

Melperone works by blocking dopamine D2 receptors, which decreases excessive dopaminergic activity that contributes to psychotic symptoms. It also has modest antagonistic effects on certain serotonin receptors, further supporting its antipsychotic action.

The appropriate dose of melperone is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to therapeutic goals and any observed side effects.

Safety data for melperone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melperone shares the dopamine D2 antagonism common to typical antipsychotics but is considered to have a slightly lower propensity for extrapyramidal side effects compared with older agents like haloperidol. Its efficacy in controlling psychosis is comparable, while its side‑effect profile may differ for individual patients.

Melperon Forte Neuraxpharm should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Melperone is administered orally, typically as a tablet taken with water. The exact timing (with or without food) and frequency are determined by the prescribing physician based on the patient’s therapeutic needs.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, agranulocytosis, seizures, and severe cardiac arrhythmias. Patients should be monitored closely for signs of these conditions, and any concerning symptoms should prompt immediate medical evaluation.

Melperone is contraindicated in patients with known hypersensitivity to melperone or other butyrophenones. Caution is advised for individuals with severe cardiovascular disease, uncontrolled hypertension, or a history of neuroleptic malignant syndrome. It should also be avoided in patients taking medications that may cause dangerous interactions.